Class Ten Companies
Ten startup health-tech companies from across the United States are joining us from August to October 2024 as part of the tenth class of the Cedars-Sinai Accelerator. This year's startup companies are creating high-tech solutions to a wide variety of healthcare challenges. Chosen from hundreds of startups, these ten teams and their innovative products represent the best and brightest from our global community of health innovators.
You can also learn about our 80+ alumni companies.
Elaborate provides a digital platform that integrates with the practitioner EMR and patient portal, automates clinical workflow, and eliminates patient messaging challenges. Elaborate's platform takes a preventive approach to healthcare providers' inbaskets, putting an end to panicked patient messages and hours of administrative time for practitioners.
Designed to combat physician burnout and improve patient understanding of their health data, Elaborate primarily serves health organizations looking to enhance their digital health capabilities and patient engagement.
Fraiya creates AI-powered tools for pregnancy ultrasound that change the way we scan, improve medical diagnoses, empower healthcare professionals, and enhance care for patients. Fraiya's platform saves the complete ultrasound examination into a structured and labeled data set, allowing follow-on rapid AI-assisted expert review to detect missed abnormalities.
Fraiya’s technology works with a wide range of clinical ultrasound systems already in service, providing AI-enabled automation to the existing fleet.
Healthplus.ai is enabling proactive surgery care through personalized complication predictions. Healthplus.ai's CE IIa certified solution, PERISCOPE®, is an AI-based decision support tool, that highly-accurately predicts infection risks using existing EHR data, facilitating early intervention and reducing unnecessary hospital stays.
Healthplus.ai uses real-time data along with validated & locally recalibrated machine learning algorithms to integrate with the existing workflow to aid clinical staff, delivering proactive and individualized care.
Hera Biotech offers the world’s first non-surgical test for endometriosis, the number one cause of female infertility. Hera's test, MetriDx™, provides definitive diagnosis and staging of endometriosis through micro-fluidic analysis of single cells.
MetriDx™ measures the expression patterns of an endometriosis-specific gene panel. Hera’s Biotech's patent-protected panel is heavily based on the expression profiles of a gene set, implicated in a number of other invasive processes. Hera Biotech primarily serves the OB/GYN and fertility solutions markets with its innovative diagnostic tool.
iCardio.ai develops artificial intelligence (AI)-based software to analyze ultrasound imaging and produce cardiology reports. Currently focused on echocardiograms, iCardio.ai recognizes multiple pathologies and identifies at-risk patients, increases visibility into abnormalities, and increases the accuracy of a diagnosis. iCardio.ai's models are based on segmentation, classification, regression analysis, and artificial intelligence for the interpretation of ultrasound imaging.
iCardio.ai enables ultrasound software and hardware companies in the research and development of AI algorithms and provides a custom application for the interpretation of ultrasound imaging.
Kinexcs develops AI-driven digital health platforms and wearables to enable and empower people with musculoskeletal conditions. Kinexcs' device, KIMIA Recover, is a post-surgical monitoring product that allows remote monitoring of joint conditions and provides live feedback to patients on a regular basis. KIMIA Recover has obtained FDA Approval, CE marking, and HSA approval.
Additionally, Kinexcs provides an AI-based digital therapist offering at-home exercises and image analysis algorithms for the detection of wound infection, excessive discharge, or bleeding during the post-surgical recovery period.
Momentum Health is a digital health platform leveraging 3D imaging and artificial intelligence to screen for scoliosis and monitor progression remotely. Its mobile application, Momentum Spine, uses a 30-second video taken on any smartphone to reconstruct a model of the torso to quantify asymmetries and predict curve progression.
Already obtaining FDA 501K clearance, Momentum Spine can be used by clinicians and care teams to remotely monitor scoliosis patients with less radiation exposure and more continuous follow-up, as well as the general population who would like to monitor their spine health.
Neu Health offers a smartphone-based platform and patient program designed to monitor and manage symptoms of Parkinson's disease and dementia.
Neu Health's platform uses artificial intelligence to monitor and translate digital measures of clinically relevant symptoms, optimizing condition management, reducing clinician burden, and ultimately providing more efficient and effective care to patients.
Noma AI develops algorithms for predictive monitoring and recognition of maternal hemorrhage. Its solution integrates with existing hospital IT and device infrastructures to monitor patients' data in real-time .
Noma AI is designing a portfolio of predictive models and clinical intelligence tools, enabling medical teams to provide the right level of care to the right patient at the right time.
Pulse Charter Connect provides a digital platform to automate processes for organ transport logistics. The platform leverages advanced technology and real-time data to improve organ transplant success rates by ensuring faster, safer, and more cost-effective transportation.
Pulse Charter Connect's platform works to streamline organ and surgical team transportation both in the air and on the ground.
